BVI announced the appointment of Jim Hollingshead as President and Chief Executive Officer, succeeding Shervin Korangy, who will continue to serve as an advisor to BVI and will also begin a new role as senior advisor to TPG Capital.

Mr. Hollingshead brings more than 20 years of experience leading and scaling medical device and life sciences companies. Most recently, he served as CEO of Insulet, a provider of insulin delivery. Prior to Insulet, Mr. Hollingshead spent 12 years at ResMed, where he last served as President of the company’s sleep and respiratory care business.

“I have long been inspired by the role that technology innovation can play in improving patient experience and outcomes,” said Mr. Hollingshead. “BVI is transforming vision care through a simple and effective mission to deliver trusted, innovative solutions tailored to the unique needs of physicians and their patients. It’s a privilege to join the BVI team as we build on the company’s already strong momentum and launch multiple new, industry-leading platforms.”

BVI provides procedural solutions for the cataract and retina surgical market. BVI has expanded its IOL platform and has introduced new product lines such as Serenity and Serenity Toric, which provide far and intermediate range vision.

In 2025, BVI received FDA approval for its Finevision HP trifocal IOL, extending its premium IOLs portfoiio in the United States. The company also debuted its FDA-cleared Leos glaucoma system, and unveiled Virtuoso, a novel dual-function phaco-vitrectomy platform designed for both cataract and vitreoretinal procedures.

“Jim’s strategic vision, insight, and track record of innovation and transformation in the medical device industry make him an excellent fit for BVI as the company continues to advance its market leadership and scale its impact globally,” said Ron Labrum, Chairman of BVI. “We also want to recognize Shervin for his leadership as BVI developed one of the most innovative product portfolios in the industry, and we know the team will continue to benefit from his expertise.”